Rick E. Winningham - 20 May 2026 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 May 2026, 18:27:58 UTC
Prior SEC filing
03 Apr 2026
Next SEC filing
27 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brett A Grimaud, Attorney-in-Fact

Key filing fact

Rick E. Winningham filed Form 4 for Theravance Biopharma, Inc. (TBPH) on 22 May 2026.

Key facts

  • This page summarizes Rick E. Winningham's Form 4 filing for Theravance Biopharma, Inc. (TBPH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 May 2026, 18:27.

Change

  • Previous filing in this sequence was filed on 03 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001302443 Primary reporting owner

Winningham Rick E

Relationship
CHIEF EXECUTIVE OFFICER, Director
Address
C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO
Signature
/s/ Brett A Grimaud, Attorney-in-Fact
Signature date
22 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBPH transaction

Ordinary Shares

Tax liability

Transaction value
Shares
-20,038
Change %
-1.2%
Price
$16.55*
Shares after
1,631,056
Date
20 May 2026
Ownership
Direct
Footnotes
F1
TBPH holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
23,400
Date
20 May 2026
Ownership
As Custodian
TBPH holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
92,567
Date
20 May 2026
Ownership
By Trust
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .